Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE

Open access

Abstract

Objectives: To review studies developing or validating a prognostic model for individual venous thromboembolism (VTE) recurrence risk following cessation of therapy for a first unprovoked VTE. Prediction of recurrence risk is crucial to informing patient prognosis and treatment decisions. The review aims to determine whether reliable prognostic models exist and, if not, what further research is needed within the field. Design: Bibliographic databases (including MEDLINE, EMBASE and the Cochrane Library) were searched using index terms relating to the clinical field and prognosis. Screening of titles, abstracts and subsequently full texts was conducted by 2 reviewers independently using predefined criteria. Quality assessment and critical appraisal of included full texts was based on an early version of the PROBAST (Prediction study Risk Of Bias Assessment Tool) for risk of bias and applicability in prognostic model studies. Setting: Studies in any setting were included. Primary and secondary outcome measures: The primary outcome for the review was the predictive accuracy of identified prognostic models in relation to VTE recurrence risk. Results: 3 unique prognostic models were identified including the HERDOO2 score, Vienna prediction model and DASH score. Quality assessment highlighted the Vienna, and DASH models were developed with generally strong methodology, but the HERDOO2 model had many methodological concerns. Further, all models were considered at least at moderate risk of bias, primarily due to the need for further external validation before use in practice. Conclusions: Although the Vienna model shows the most promise (based on strong development methodology, applicability and having some external validation), none of the models can be considered ready for use until further, external and robust validation is performed in new data. Any new models should consider the inclusion of predictors found to be consistently important in existing models (sex, site of index event, D-dimer), and take heed of several methodological issues identified through this review. PROSPERO registration number: CRD42013003494.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2016-011190

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PRISMA flow diagram showing the quantity of research available.
Figure 1 PRISMA flow diagram showing the quantity of research available.CC BY · PubMed Central
Figure 2 Events per predictor (EPP) for included studies, based on total sample size and number of predictors. NB: lines represent number of events required to maintain EPP=x for given number of predictors.
Figure 2 Events per predictor (EPP) for included studies, based on total sample size and number of predictors. NB: lines represent number of events required to maintain EPP=x for given number of predictors.CC BY · PubMed Central
Figure 3 Final model sample size compared to total & selection sample size. Final model sample size=total sample minus patients with missing information in any predictor included in the final model; Predictor selection sample size=total sample size minus patients with missing predictor information in any predictor considered for inclusion in the model using a selection procedure.
Figure 3 Final model sample size compared to total & selection sample size. Final model sample size=total sample minus patients with missing information in any predictor included in the final model; Predictor selection sample size=total sample size minus patients with missing predictor information in any predictor considered for inclusion in the model using a selection procedure.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 11

  1. Ramalle-Gomara, 2008, Low risk of pulmonary embolism after discontinuing anticoagulant treatment for deep venous thrombosis?, FMC Formacion Med Continuada Aten Primaria, 15, 480
  2. Rodger MA , Rodger M , Kovacs M , et al . Extended follow-up of the multi-center prospective cohort that derived the ‘men continue and HERDOO2’ clinical decision rule identifying low risk unprovoked patients. Journal of Thrombosis and Haemostasis 2011; Conference: 23rd Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting Kyoto Japan. Conference Start: 20110723 Conference End: 20110728. Conference Publication: (var.pagings):39–40.
  3. Lazo-Langner A , Abdulrehman J , Taylor EJ , et al . The use of the REVERSE study clinical prediction rule for risk stratification after initial anticoagulation results in decreased recurrences in patients with idiopathic venous thromboembolism. Journal of Thrombosis and Haemostasis; Conference: 24th Congress of the International Society on Thrombosis and Haemostasis Amsterdam Netherlands. Conference Start: 20130629 Conference End: 20130704. Conference Publication: (varpagings)11 (pp 879), 201 2013(var.pagings):879.
  4. Marcucci M , Eichinger S , Iorio A , et al . External validation and updating of the Vienna Prediction Model for recurrent venous thromboembolism using a pooled individual patient data database. Journal of Thrombosis and Haemostasis; Conference: 24th Congress of the International Society on Thrombosis and Haemostasis Amsterdam Netherlands. Conference Start: 20130629 Conference End: 20130704. Conference Publication: (varpagings)11 (pp 879-880) 2013(var.pagings):879–80.
  5. Rodger M , Kovacs M , Le GG , et al . The REVERSE I and II studies: impact of using. Men continue and HERDOO2 clinical decision rule to guide anticoagulant therapy in patients with first unprovoked venous thromboembolism. Journal of Thrombosis and Haemostasis; Conference: 24th Congress of the International Society on Thrombosis and Haemostasis Amsterdam Netherlands. Conference Start: 20130629 Conference End: 20130704. Conference Publication: (varpagings)11 (pp 114), 201 2013(var.pagings):114.
  6. Raskob GE , Anthonie LWA , Prins MH , et al . Risk assessment for recurrent venous thromboembolism (VTE) after 6-14 months of anticoagulant treatment. Journal of Thrombosis and Haemostasis 2011; Conference: 23rd Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting Kyoto Japan. Conference Start: 20110723 Conference End: 20110728. Conference Publication: (var.pagings):857–8.
  7. Tosetto A , Iorio A , Marcucci M , et al . Clinical prediction of VTE recurrence in patients with previous unprovoked venous thromboembolism. Results from an individual-level meta-analysis. Pathophysiology of Haemostasis and Thrombosis 2010; Conference: 21st International Congress on Thrombosis—The Start of a New Era Antithrombotic Agents Milan Italy. Conference Start: 20100706 Conference End: 20100709. Conference Publication: (var.pagings):A29.
  8. Tosetto A , Lorio A , Marcucci M , et al . Clinical prediction guide to predict thrombosis recurrence after a first unprovoked venous thromboembolism. Journal of Thrombosis and Haemostasis 2009; Conference: 22nd Congress of the International Society of Thrombosis and Haemostasis Boston, MA United States. Conference Start: 20090711 Conference End: 20090716. Conference Publication: (var.pagings):266.
  9. Eichinger S , Heinze G , Kyrle PA . D-Dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna Prediction Model. Journal of Thrombosis and Haemostasis; Conference: 24th Congress of the International Society on Thrombosis and Haemostasis Amsterdam Netherlands. Conference Start: 20130629 Conference End: 20130704. Conference Publication: (varpagings) 11 (pp 115), 201 2013 (var.pagings):115.
  10. Eichinger S , Heinze G , Kyrle PA . D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model. Vasa—Journal of Vascular Diseases; Conference: 16th Tri-Country Congress of the Austrian, German and Swiss Society of Angiology 2013 Graz Austria. Conference Start: 20130915 Conference End: 20130918. Conference Publication: (varpagings) 42 (pp 36), 20 2014 (var.pagings):36-Journal.
  11. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation (Structured abstract). 2016. http://onlinelibrary.wiley.com/o/cochrane/clhta/articles/HTA-32013001066/frame.html (accessed 29 Apr 2016).

Cited by

See all 89

Metadata

Authors
Ensor, J., Riley, R. D., Moore, D., Snell, K. I. E., Bayliss, S., & Fitzmaurice, D.
Affiliations
  • Keele University (GB)
  • University of Birmingham (GB)
Corresponding author
Ensor, Joie
Venue
BMJ Open
Publisher
BMJ
Published
2016-05
Volume
6
Issue
5
Pages
e011190
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2346047977
Cited by
84
References
53
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 9 · 2020: 11 · 2019: 15 · 2018: 16 · 2017: 10 · 2016: 4
FWCI
2.68
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMJ Open (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
  • Keele Research Repository (Keele University) (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • HighWire Press Open Archive (submittedVersion)
Funders
Health Technology Assessment Programme (10/94/02)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Keywords
venous thromboembolism, VTE recurrence, prognostic model, recurrence risk prediction, DASH score, risk of bias, external validation, D-dimer, sex
MeSH terms
Anticoagulants, Humans, Prognosis, Recurrence, Risk Factors, Decision Support Systems, Clinical, Venous Thromboembolism, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE. https://app.cochat.ai/papers/10.1136/bmjopen-2016-011190
The paper
Ensor, J., Riley, R. D., Moore, D., Snell, K. I. E., Bayliss, S., & Fitzmaurice, D. (2016). Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE. BMJ Open. https://doi.org/10.1136/bmjopen-2016-011190

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.